FDA Recalls Eye Ointment Product Due to Sterility Assurance Failure
The FDA is recalling Major LubriFresh PM eye ointment due to lack of assurance of sterility. Approximately 282,564 units were distributed to accounts in Rhode Island and Colorado.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile ophthalmic product without reported illnesses or injuries. While the lack of sterility assurance on an eye ointment presents a potential risk of infection, no actual contamination or adverse events have been reported in the source, warranting a High rating for this precautionary recall.
Plain-English summary
The FDA is recalling Major LubriFresh PM Nighttime Ointment, a sterile eye lubricant manufactured by Amman Pharmaceutical Industries. The product contains mineral oil and white petrolatum and is available in 0.125 ounce (3.5 gram) tubes with NDC 0904-6488-38.
The recall is due to lack of assurance of sterility. Approximately 282,564 units were distributed to accounts in Rhode Island and Colorado. The affected lots are 184001, 184002, and 184003 (expiration 11/24) and lots 184004, 184005, and 184006 (expiration 12/24).
Consumers who have purchased this product should discontinue use. Patients with questions should contact their healthcare provider or pharmacist.
The recalled product
- Product
- MAJOR LubriFresh P.M. Nighttime Ointment, Lubricant Eye Ointment, Sterile, 0.125 OZ (3.5g), Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, Made in Jordan, NDC: 0904-6488-38.
- Manufacturer
- AMMAN PHARMACEUTICAL INDUSTRIES
- Category
- Drug — Ophthalmic
- Affected units
- 282,564
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot: 184001 EXP: 11/24
- 184002 EXP: 11/24
- 184003 EXP: 11/24
- Lot: 184004 EXP: 12/24
- Lot: 184005 EXP: 12/24
- Lot:184006 EXP:12/24
Distribution
Part of a larger recall action
This product is one of 17 recalled by AMMAN PHARMACEUTICAL INDUSTRIES under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · AMMAN PHARMACEUTICAL INDUSTRIES
See all →- HighTRP Natural Eyes Stye Relief sterile eye ointment recalled for lack of sterility assurance
FDA (Drugs) · 2023-09-27
- HighFDA Recalls TRP Natural Eyes Eye Drops Due to Sterility Assurance Issue
FDA (Drugs) · 2023-09-27
- HighTRP Natural Eyes Sterile Eye Drops Recalled Due to Sterility Assurance
FDA (Drugs) · 2023-09-27
- HighTRP Natural Eyes Red Eye Relief eye drops recalled due to sterility concerns
FDA (Drugs) · 2023-09-27
- Highoctiq Lubricating Eye Drops Recalled Due to Sterility Assurance Defect
FDA (Drugs) · 2023-09-27
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15